OTC · PURE
Consumer Defensive · Household & Personal Products
$0.07
Down-$0.01 (-7.14%)
Updated Nov 5, 2026, 3:02 AM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · PURE
1M range · 0 trading sessions · Daily adjusted prices
PURE does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning PURE.
Company
Market Activity
Research & News
PURE research
Filterable reporting and market headlines.
Filters are reflected in the page URL for sharing and back-button support.
2 matching articles.
Yahoo · Oct 29, 2026
EL CAJON, Calif., October 29, 2026--PURE Bioscience, Inc. (OTCQB: PURE) ("PURE," the "Company," or "we"), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal year ended July 31, 2026.
Benzinga · Oct 29, 2026
PURE Bioscience (OTC:PURE) reported $662.000 thousand in sales this quarter. This is a 13.35 percent decrease over sales of $764.000 thousand the same period last year.
The latest Smart Investors Daily articles mentioning PURE.
